[Federal Register Volume 68, Number 75 (Friday, April 18, 2003)]
[Notices]
[Page 19189]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-9637]



[[Page 19189]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration

[A-570-852]


Creatine Monohydrate from the People's Republic of China: Final 
Results of Changed Circumstances Review

AGENCY: Import Administration, International Trade Administration, 
Department of Commerce.

ACTION: Notice of Final Results of Changed Circumstances Antidumping 
Duty Administrative Review.

-----------------------------------------------------------------------

SUMMARY: On February 28, 2003, the Department of Commerce published a 
notice of initiation and preliminary results of its changed 
circumstances review in creatine monohydrate from the People's Republic 
of China examining whether Suzhou Sanjian Nutrient and Health Products 
Co., Ltd. is the successor-in-interest of Suzhou Sanjian Fine Chemical 
Co. Ltd. We gave interested parties an opportunity to comment on the 
preliminary results of review but received no comments. The final 
results do not differ from the preliminary results of review, in which 
we found that Suzhou Sanjian Nutrient and Health Products Co., Ltd. is 
the successor-in-interest of Suzhou Sanjian Fine Chemical Co. Ltd.

EFFECTIVE DATE: April 18, 2003.

FOR FURTHER INFORMATION CONTACT: Blanche Ziv or Julie Santoboni, Import 
Administration, International Trade Administration, U.S. Department of 
Commerce, 14th Street and Constitution Avenue, NW, Washington, DC 
20230; telephone (202) 482-4207 and (202) 482-4194, respectively.

SUPPLEMENTARY INFORMATION:

Background:

    On February 28, 2003, in accordance with Section 751(b) of the Act 
and 19 CFR 351.216 and 351.221(c)(3), the Department published its 
preliminary results in the Federal Register, preliminarily finding 
Suzhou Sanjian Nutrient and Health Products Co., Ltd. (``Suzhou Health 
Products'') to be the successor-in-in terest to Suzhou Sanjian Fine 
Chemical Co. Ltd. (``Suzhou Chemical''). (See Creatine Monohydrate from 
the People's Republic of China; Initiation and Preliminary Results of 
Antidumping Duty Changed Circumstances Review, 68 FR 9635 
(``Preliminary Results'')). We invited interested parties to comment on 
these findings. No comments were received.

Scope of the Review

    Imports covered by this review are creatine monohydrate, which is 
commonly referred to as ``creatine.'' The chemical name for creatine 
monohydrate is N-(aminoiminomethyl)-N-methylgycine monohydrate. The 
Chemical Abstracts Service (``CAS'') registry number for this product 
is 6020-87-7. Creatine monohydrate in its pure form is a white, 
tasteless, odorless powder, that is a naturally occurring metabolite 
found in muscle tissue. Creatine monohydrate is provided for in 
subheading 2925.20.90 of the Harmonized Tariff Schedule of the United 
States (``HTSUS''). Although the HTSUS subheading and the CAS registry 
number are provided for convenience and customs purposes, the written 
description of the merchandise under review is dispositive.

Final Results of Review

    Because we received no comments on the preliminary results, for the 
reasons stated in the Preliminary Results and based on the facts on the 
record, we find Suzhou Health Products to be the successor-in-interest 
to Suzhou Chemical for antidumping duty cash deposit purposes. In order 
to make this determination, we examined the management structure of 
Suzhou Chemical, including, but not limited to, copies of business 
licenses, financial statements, sales documents and organizational 
charts. Since the record shows that Suzhou Health Products maintained 
the same senior management, organizational structure, production 
facilities, supplier relationships and customers, among other things, 
we determine that Suzhou Health Products is the successor-in-interest 
to Suzhou Chemical.
    Suzhou Health Products will be assigned the same antidumping duty 
cash-deposit rate (i.e., a 50.32 percent antidumping duty cash-deposit 
rate) with respect to the subject merchandise as Suzhou Chemical, its 
predecessor company. This cash deposit requirement will be effective 
upon publication of this notice of final results of changed 
circumstances review for all shipments of the subject merchandise 
entered, or withdrawn from warehouse, for consumption on or after the 
publication date. This cash deposit rate shall remain in effect until 
publication of the final results of the next administrative review in 
which Suzhou Health Products participates.
    This determination is issued and published in accordance with 
sections 751(b)(1) and 777(i)(1) of the Act.

    Dated: April 14, 2003.
Joseph A. Spetrini,
Acting Assistant Secretary for Import Administration.
[FR Doc. 03-9637 Filed 4-17-03; 8:45 am]
BILLING CODE 3510-DS-S